Fortrea Holdings (FTRE) Common Equity (2022 - 2026)

Fortrea Holdings (FTRE) posted Common Equity of $525.9 million for Q1 2026, down 6.67% on a QoQ basis from $563.5 million in Q4 2025, and down 38.76% year-over-year from $858.8 million in Q1 2025.

Fortrea Holdings (FTRE) Common Equity (2022 - 2026) Analysis & Trends

Fortrea Holdings' Common Equity history runs 5 years deep, the most recent figure standing at $525.9 million for Q1 2026.

  • Quarterly Common Equity fell 38.76% year-over-year to $525.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $525.9 million (down 38.76% YoY) and the FY2025 annual result came in at $563.5 million, down 58.64% from the prior year.
  • Common Equity was $525.9 million for Q1 2026 at Fortrea Holdings, down from $563.5 million in the prior quarter.
  • Across five years, Common Equity topped out at $3.4 billion in Q1 2023 and bottomed at $525.9 million in Q1 2026.
  • A 5-year average of $1.6 billion and a median of $1.5 billion in 2024 frame the typical range for Common Equity.
  • Annual changes were most pronounced in 2024 — Common Equity decreased 10.47% — and 2025, when it plunged 61.63%.
  • Fortrea Holdings' Common Equity stood at $3.3 billion in 2022, then tumbled by 48.68% to $1.7 billion in 2023, then dropped by 20.52% to $1.4 billion in 2024, then tumbled by 58.64% to $563.5 million in 2025, then declined by 6.67% to $525.9 million in 2026.
  • Business Quant data shows FTRE's Common Equity at $525.9 million in Q1 2026, $563.5 million in Q4 2025, and $580.8 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Common Equity (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 251.12 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -98.34 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 4.76 Bn
4 NuCana 279.75 Bn 279.75 Bn - 32.36 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 19.36 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 31.42 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - 795.79 Mn
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 1.50 Bn
10 Fortrea Holdings 1.83 Bn 1.68 Bn 123.60 Mn 525.90 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 525.90 Mn
Dec 31, 2025 563.50 Mn
Sep 30, 2025 580.80 Mn
Jun 30, 2025 589.20 Mn
Mar 31, 2025 858.80 Mn
Dec 31, 2024 1.36 Bn
Sep 30, 2024 1.51 Bn
Jun 30, 2024 1.46 Bn
Mar 31, 2024 1.59 Bn
Dec 31, 2023 1.71 Bn
Sep 30, 2023 1.69 Bn
Jun 30, 2023 1.75 Bn
Mar 31, 2023 3.40 Bn
Dec 31, 2022 3.34 Bn
Jun 30, 2022 3.30 Bn